​
​

Benitec Biopharma (BNTC) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Benitec Biopharma Revenue Highlights

00

Main Segment (Y)

License

Main Geography (Y)

License

Benitec Biopharma Revenue by Period

Benitec Biopharma Revenue by Year

DateRevenueChange
2024-06-30--100.00%
2023-06-30$75.00K2.74%
2022-06-30$73.00K23.73%
2021-06-30$59.00K-39.18%
2020-06-30$97.00K-99.14%
2019-06-30$11.32M2384.77%
2018-06-30$455.45K1.14%
2017-06-30$450.31K29.96%
2016-06-30$346.51K-58.21%
2015-06-30$829.13K-18.53%
2014-06-30$1.02M86.49%
2013-06-30$545.73K-

Benitec Biopharma generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Benitec Biopharma Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30--100.00%
2024-03-31$6.00K100.00%
2023-12-31-100.00%
2023-09-30--100.00%
2023-06-30$7.00K-87.04%
2023-03-31$54.00K285.71%
2022-12-31$14.00K-97.03%
2022-09-30$472.00K100.00%
2022-06-30--100.00%
2022-03-31$48.00K92.00%
2021-12-31$25.00K100.00%
2021-09-30--100.00%
2021-06-30$2.00K100.00%
2021-03-31$1.00K-
2020-12-31$1.00K-98.18%
2020-09-30$55.00K-237.50%
2020-06-30$-40.00K-242.86%
2020-03-31$28.00K-63.64%
2019-12-31$77.00K133.33%
2019-09-30$33.00K-94.87%
2019-06-30$643.00K14.82%
2019-03-31$560.00K-90.03%
2018-12-31$5.62M1.76%
2018-09-30$5.52M18107.12%
2018-06-30$30.31K-69.18%
2018-03-31$98.32K-56.87%
2017-12-31$227.97K130.61%
2017-09-30$98.85K22.39%
2017-06-30$80.77K-56.04%
2017-03-31$183.73K81.64%
2016-12-31$101.15K19.48%
2016-09-30$84.66K63.84%
2016-06-30$51.67K-14.43%
2016-03-31$60.39K-20.80%
2015-12-31$76.25K-51.80%
2015-09-30$158.20K-52.40%
2015-06-30$332.32K-1372.59%
2015-03-31$-26.11K-

Benitec Biopharma generated - in revenue during Q1 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Benitec Biopharma Revenue Breakdown

Benitec Biopharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceJun 23Jun 22Jun 20
License$75.00K$73.00K-
Grant--$5.00K

Benitec Biopharma's latest annual revenue breakdown by segment (product or service), as of Jun 23: License (100.00%).

Quarterly Revenue by Product

Product/ServiceMar 21Dec 20Sep 20
License$1.00K$1.00K$55.00K
Service---
Royalty---

Benitec Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Mar 21: License (100.00%).

Benitec Biopharma Revenue Breakdown by Country

Annual Revenue by Country

CountryJun 22Jun 20Jun 19
License$73.00K--
Grant-$5.00K-
AUSTRALIA--$14.63M

Benitec Biopharma's latest annual revenue breakdown by geography, as of Jun 22: License (100.00%).

Benitec Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CAPRCapricor Therapeutics$25.18M$2.26B
SGTXSigilon Therapeutics$12.94M$5.90M
CBIOGyre Therapeutics$794.00K-
APLMApollomics--
BPTHBio-Path--
ZURAZura Bio--
NXTCNextCure--
BNTCBenitec Biopharma--
ALRNAileron Therapeutics--
ZVSAZyVersa Therapeutics--
ONCROncorus--
LABPLandos Biopharma--
VIRIVirios Therapeutics--
EFTReFFECTOR Therapeutics--
DFFNCervoMed--

BNTC Revenue FAQ

What is Benitec Biopharma’s yearly revenue?

Benitec Biopharma's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $75K, representing an increase of 2.74% compared to 2022. BNTC's yearly revenue for 2022 was $73K, representing an increase of 23.73% compared to 2021.

What is Benitec Biopharma’s quarterly revenue?

Benitec Biopharma's quarterly revenue for Q1 2025 was $0, a 100.00% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $0, a -100.00% decrease from the previous quarter (Q3 2024), and a -100.00% decrease year-over-year (Q4 2023). BNTC's quarterly revenue for Q3 2024 was $6K, a 100.00% increase from the previous quarter (Q2 2024), and a -88.89% decrease year-over-year (Q3 2023).

What is Benitec Biopharma’s revenue growth rate?

Benitec Biopharma's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are Benitec Biopharma’s revenue streams?

Benitec Biopharma's revenue streams in n 23 are License

What is Benitec Biopharma’s main source of revenue?

For the fiscal year ending Jun 23, the largest source of revenue of Benitec Biopharma was License. This segment made a revenue of $75K, representing 100.00% of the company's total revenue.